NASDAQ

ArriVent BioPharma, Inc. (AVBP)

♥ 662 Thanks from members

Live price chart, market sentiment, and community perspectives for ArriVent BioPharma, Inc. (NASDAQ: AVBP).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: ArriVent BioPharma ScientistsLeadership: Mei-Ling Chen (CEO)Leadership: Stuart Lutzker (CSO)Holder: Hillhouse CapitalHolder: Sofinnova InvestmentsHolder: OrbiMedFirmagonFurmonertinibOncology Therapeutics#AVBP#ArriVent BioPharma#Cancer Therapeutics#Biotech IPO#NASDAQ AVBP